Korea Arlico PharmLtd Management

Management Kriterienprüfungen 0/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Hang-Gu Lee

Geschäftsführender

n/a

Gesamtvergütung

Prozentsatz des Geschäftsführergehaltsn/a
Amtszeit als Geschäftsführerno data
Eigentum des Geschäftsführers39.1%
Durchschnittliche Amtszeit des Managementskeine Daten
Durchschnittliche Amtszeit der Vorstandsmitgliederkeine Daten

Jüngste Management Updates

Recent updates

There's Reason For Concern Over Korea Arlico Pharm Co.,Ltd.'s (KOSDAQ:260660) Price

Aug 04
There's Reason For Concern Over Korea Arlico Pharm Co.,Ltd.'s (KOSDAQ:260660) Price

Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?

Mar 24
Is Korea Arlico PharmLtd (KOSDAQ:260660) Using Too Much Debt?

Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?

Mar 02
Should You Be Adding Korea Arlico PharmLtd (KOSDAQ:260660) To Your Watchlist Today?

Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares

Feb 12
Korea Arlico PharmLtd's (KOSDAQ:260660) Shareholders Are Down 50% On Their Shares

What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?

Jan 25
What Is The Ownership Structure Like For Korea Arlico Pharm Co.,Ltd. (KOSDAQ:260660)?

Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?

Jan 04
Should You Use Korea Arlico PharmLtd's (KOSDAQ:260660) Statutory Earnings To Analyse It?

Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?

Dec 16
Is Korea Arlico PharmLtd (KOSDAQ:260660) A Risky Investment?

Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?

Nov 25
Are Strong Financial Prospects The Force That Is Driving The Momentum In Korea Arlico Pharm Co.,Ltd.'s KOSDAQ:260660) Stock?

Geschäftsführer

Hang-Gu Lee (63 yo)

no data

Amtszeit

Mr. Hang-Gu Lee is Chief Executive Officer of Korea Arlico Pharm Co.,Ltd.